Preferences and values for government policies on infectious disease outbreaks and epidemics for the Japanese population: a conjoint analysis

References

• Organisation for Economic Co-operation and Development. The territorial impact of COVID-19: managing the crisis across levels of government. OECD policy responses to coronavirus (COVID-19). Paris (France): Organisation for Economic Co-operation and Development; 2020.
   Google Scholar
• Mathieu E, Ritchie H, Rodés-Guirao L, et al. Coronavirus pandemic (COVID-19) [Internet]. OurWorldInData.org; 2020 [cited 2023 Apr 6]. Available from: https://ourworldindata.org/coronavirus
   Google Scholar
• Halperin DT, Hearst N, Hodgins S, et al. Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here. BMC Public Health. 2021;21(1):2084. doi: 10.1186/s12889-021-12082-z.
   PubMed Web of Science ®Google Scholar
• Organisation for Economic Co-operation and Development. Access to COVID-19 vaccines: global approaches in a global crisis. OECD policy responses to coronavirus (COVID-19). Paris (France): Organisation for Economic Co-operation and Development; 2021.
   Google Scholar
• Kawata K, Nakabayashi M. Determinants of COVID-19 vaccine preference: a survey study in Japan. SSM Popul Health. 2021;15:100902. doi: 10.1016/j.ssmph.2021.100902.
   PubMed Web of Science ®Google Scholar
• Igarashi A, Nakano Y, Yoneyama-Hirozane M. Public preferences and willingness to accept a hypothetical vaccine to prevent a pandemic in Japan: a conjoint analysis. Expert Rev Vaccines. 2022;21(2):241–248. doi: 10.1080/14760584.2022.2016402.
   PubMed Web of Science ®Google Scholar
• Ohmura H. Analysis of social combinations of COVID-19 vaccination: evidence from a conjoint analysis. PLoS One. 2022;17(1):e0261426. doi: 10.1371/journal.pone.0261426.
   PubMed Web of Science ®Google Scholar
• Okamoto S, Kamimura K, Komamura K. COVID-19 vaccine hesitancy and vaccine passports: a cross-sectional conjoint experiment in Japan. BMJ Open. 2022;12(6):e060829. doi: 10.1136/bmjopen-2022-060829.
   PubMed Web of Science ®Google Scholar
• Schwarzinger M, Watson V, Arwidson P, et al. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;6(4):e210–e221. doi: 10.1016/S2468-2667(21)00012-8.
   PubMed Web of Science ®Google Scholar
• Motta M. Can a COVID-19 vaccine live up to Americans’ expectations? A conjoint analysis of how vaccine characteristics influence vaccination intentions. Soc Sci Med. 2021;272:113642. doi: 10.1016/j.socscimed.2020.113642.
   PubMed Web of Science ®Google Scholar
• Kreps S, Prasad S, Brownstein JS, et al. Factors associated with US adults’ likelihood of accepting COVID-19 vaccination. JAMA Netw Open. 2020;3(10):e2025594. doi: 10.1001/jamanetworkopen.2020.25594.
   PubMed Web of Science ®Google Scholar
• Kaplan RM, Milstein A. Influence of a COVID-19 vaccine’s effectiveness and safety profile on vaccination acceptance. Proc Natl Acad Sci U S A. 2021;118(10):e2021726118.
   PubMed Web of Science ®Google Scholar
• Wang K, Wong EL, Cheung AW, et al. Impact of information framing and vaccination characteristics on parental COVID-19 vaccine acceptance for children: a discrete choice experiment. Eur J Pediatr. 2022;181(11):3839–3849. doi: 10.1007/s00431-022-04586-6.
   PubMed Web of Science ®Google Scholar
• Kubo Y, Okada I. COVID-19 health certification reduces outgroup bias: evidence from a conjoint experiment in Japan. Humanit Soc Sci Commun. 2022;9(1):306. doi: 10.1057/s41599-022-01324-z.
   PubMedGoogle Scholar
• Loría-Rebolledo LE, Ryan M, Watson V, et al. Public acceptability of non-pharmaceutical interventions to control a pandemic in the UK: a discrete choice experiment. BMJ Open. 2022;12(3):e054155. doi: 10.1136/bmjopen-2021-054155.
   PubMed Web of Science ®Google Scholar
• Sicsic J, Blondel S, Chyderiotis S, et al. Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experiment. Eur J Health Econ. 2023;24(1):81–98. doi: 10.1007/s10198-022-01454-w.
   PubMed Web of Science ®Google Scholar
• Blayac T, Dubois D, Duchêne S, et al. What drives the acceptability of restrictive health policies: an experimental assessment of individual preferences for anti-COVID 19 strategies. Econ Model. 2022;116:106047. doi: 10.1016/j.econmod.2022.106047.
   PubMed Web of Science ®Google Scholar
• Li L, Long D, Rouhi Rad M, et al. Stay-at-home orders and the willingness to stay home during the COVID-19 pandemic: a stated-preference discrete choice experiment. PLoS One. 2021;16(7):e0253910. doi: 10.1371/journal.pone.0253910.
   PubMed Web of Science ®Google Scholar
• Eshun-Wilson I, Mody A, McKay V, et al. Public preferences for social distancing policy measures to mitigate the spread of COVID-19 in Missouri. JAMA Netw Open. 2021;4(7):e2116113. doi: 10.1001/jamanetworkopen.2021.16113.
   PubMed Web of Science ®Google Scholar
• Reed S, Gonzalez JM, Johnson FR. Willingness to accept trade-offs among COVID-19 cases, social-distancing restrictions, and economic impact: a nationwide US study. Value Health. 2020;23(11):1438–1443. doi: 10.1016/j.jval.2020.07.003.
   PubMed Web of Science ®Google Scholar
• Manipis K, Street D, Cronin P, et al. Exploring the trade-off between economic and health outcomes during a pandemic: a discrete choice experiment of lockdown policies in Australia. Patient. 2021;14(3):359–371. doi: 10.1007/s40271-021-00503-5.
   PubMedGoogle Scholar
• Filipe L, de Almeida SV, Costa E, et al. Trade-offs during the COVID-19 pandemic: a discrete choice experiment about policy preferences in Portugal. PLoS One. 2022;17(12):e0278526. doi: 10.1371/journal.pone.0278526.
   PubMed Web of Science ®Google Scholar
• Mühlbacher AC, Sadler A, Jordan Y. Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics. Eur J Health Econ. 2022;23(9):1483–1496. doi: 10.1007/s10198-022-01438-w.
   PubMed Web of Science ®Google Scholar
• Homaie Rad E, Hajizadeh M, Yazdi-Feyzabadi V, et al. How much money should be paid for a patient to isolate during the COVID-19 outbreak? A discrete choice experiment in Iran. Appl Health Econ Health Policy. 2021;19(5):709–719. doi: 10.1007/s40258-021-00671-3.
   PubMed Web of Science ®Google Scholar
• Krauth C, Oedingen C, Bartling T, et al. Public preferences for exit strategies from COVID-19 lockdown in Germany-a discrete choice experiment. Int J Public Health. 2021;66:591027. doi: 10.3389/ijph.2021.591027.
   PubMed Web of Science ®Google Scholar
• Mouter N, Hernandez JI, Itten AV. Public participation in crisis policymaking. How 30,000 Dutch citizens advised their government on relaxing COVID-19 lockdown measures. PLoS One. 2021;16(5):e0250614. doi: 10.1371/journal.pone.0250614.
   PubMed Web of Science ®Google Scholar
• Lagevrio Capsules 200 mg. Report on the deliberation results. Tokyo (Japan): Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau; 2021.
   Google Scholar
• Paxlovid PACK. Report on the deliberation results. Tokyo (Japan): Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau; 2022.
   Google Scholar
• Xocova Tablets 125 mg. Report on the deliberation results. Tokyo (Japan): Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau; 2022.
   Google Scholar
• Population Estimates. Population estimates/intercensal adjustment of current population estimates intercensal adjustment of current population estimates 2015-2020 table 10 [Internet]. Tokyo (Japan): Statistic Bureau, Ministry of Internal Affairs and Communications; 2022 [cited 2023 May 10]. Available from: https://www.e-stat.go.jp/en/stat-search/files?stat_infid=000032166848
   Google Scholar
• Data on Tax Revenue [Internet]. Tokyo (Japan): Ministry of Finance; 2022 [cited 2023 Feb 9]. Available from: https://www.mof.go.jp/tax_policy/summary/condition/a03.htm. Japanese.
   Google Scholar
• Population Estimates. Annual report (October 1, 2022) Table 1 [Internet]. Tokyo (Japan): Statistic Bureau, Ministry of Internal Affairs and Communications; 2023 [cited 2023 May 10]. Available from: https://www.e-stat.go.jp/en/stat-search/files?tclass=000001007604&cycle=7&year=20220
   Google Scholar
• #Your Corona Budget [Internet]. Tokyo (Japan): Japan Broadcasting Corporation; 2022. [cited 2023 Apr 6]. Available from: https://www3.nhk.or.jp/news/special/covid19-money/. Japanese.
   Google Scholar
• Annual national medical care expenditure and ratio to gross domestic product (table 1). Estimates of national medical care expenditure. 2020. Tokyo (Japan): Ministry of Health, Labour and Welfare; 2022. Japanese.
   Google Scholar
• Measures for Resuming Cross-Border Travel [Internet]. Tokyo (Japan): Ministry of Foreign Affairs of Japan; 2022 [cited 2023 Apr 6]. Available from: https://www.mofa.go.jp/ca/cp/page22e_000925.html
   Google Scholar
• Ethical guidelines for life science and medical research involving human subjects. Tokyo (Japan): Ministry of Education Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare; 2021, partial revision in 2022. Japanese.
   Google Scholar